VENETOCLAX

VENETOCLAX (11630D)

venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
11630D
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL)
Treatment phase: Dose titration for relapsed/refractory disease
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,706.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta

VENETOCLAX (12188L)

venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
12188L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Initial treatment in first-line therapy - Dose titration (weeks 1 to 4 of a 5-week ramp-up schedule)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,706.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta

VENETOCLAX (14584N)

venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
14584N
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Initial treatment in first-line therapy with ibrutinib - Dose titration (cycle 4)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,706.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta

VENETOCLAX (14599J)

Supply only until 01/12/2026
venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
14599J
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Grandfather treatment - Transitioning from non-PBS to PBS-subsidised supply of first-line therapy
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,706.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta

VENETOCLAX (15361L)

venetoclax 10 mg tablet [14] (&) venetoclax 50 mg tablet [7] (&) venetoclax 100 mg tablet [7] (&) venetoclax 100 mg tablet [14], 1 pack
15361L
Body System:
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL)
Treatment phase: Initial treatment in first-line therapy with acalabrutinib - Dose titration (cycle 3)
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $1,706.83 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Venclexta